Footnote

The numbers are read by 9:31.
The footnotes aren't.

Every 10-Q, read line by line against the one before it. You get what changed in the disclosure — the cases, the covenants, the segments, the people — quoted from the filing, the morning it lands.

Cencora · 10-Q · filed 5 Aug 2026 Note 10 — Legal Matters

Last quarter The jury returned a verdict finding ABDC liable for public nuisance and assessed damages against the defendants.

This quarter The jury returned a verdict finding ABDC liable for public nuisance. On May 8, 2026, the City of Baltimore voluntarily dismissed all claims against the Company with prejudice.

      Free while in test. One email per filing, nothing else. Leave any time.

      A real briefing

      What landed the morning Cencora filed

      Nothing here is in the earnings release. Every quote is taken verbatim from the 10-Q.

      COR
      10-Q · filed 5 Aug 2026 · quarter ended 30 Jun 2026
      The read

      Baltimore dismissed all claims against the Company with prejudice, and the opioid liability was reduced by $102.0m on that dismissal. The FTC has requested information on the MWI Animal Health merger with Covetrus, and the U.S. Consulting Services business was divested in April. The Board authorised a new $2.0bn repurchase program, and the CFO changed from James F. Cleary to Eva C. Boratto.

      1
      Opioid lawsuits and investigations

      Baltimore voluntarily dismissed all claims against the Company with prejudice

      Following the Maryland Supreme Court's remand, the City dismissed on 8 May 2026. That removes the Company from the Baltimore opioid litigation.

      On May 8, 2026, the City of Baltimore voluntarily dismissed all claims against the Company with prejudice.

      2
      Operating expenses

      Opioid liability reduced $102.0m on the dismissal

      A reduction that was not in the previous filing, recorded in the three months to 30 June 2026.

      Litigation and opioid-related (credit) expenses, net in the three months June 30, 2026 includes a $102.0 million reduction of opioid liability related to the dismissal of opioid litigation.

      3
      Note 3 — Assets and liabilities held for sale

      FTC requested information on the MWI Animal Health merger with Covetrus

      A second request received 20 May 2026 on a disposal the Company had already classified as held for sale.

      On May 20, 2026, the Company received a request for additional information and documentary materials from the Federal Trade Commission (the “FTC”) in connection with the FTC’s review of MWI Animal Health’s proposed merger with Covetrus, Inc.

      4
      Signatures

      CFO changed from James F. Cleary to Eva C. Boratto

      Found in the signature block, where officer changes appear before they are announced anywhere else in the filing.

      How it works

      Three steps, none of them yours

      1. The filing landsWe watch EDGAR for the companies you follow. A new 10-Q or 10-K triggers the rest.
      2. We read it against the last oneThe whole document, not a summary — this quarter's text beside last quarter's, start to finish.
      3. You get what changedRanked by how much it moves what the filing says, each one quoted, with a link to the passage.
      Editorial rules

      What we leave out, and what we look for

      A briefing that reports everything is a briefing nobody reads. These are the lines we hold.

      Always reported

      • A case, claim or obligation beginning or ending
      • A regulator or court acting
      • A segment, policy or metric redefined
      • A customer or counterparty named, gained or lost
      • A covenant, guarantee or contingency appearing
      • A change in who runs or signs for the business